Frequently bought together

Brand : ETORIA

ETORIA 90/MG FC TAB 28/FC TAB

60.45

Sku : I-014553
Key features
ETORIA 90 mg film-coated tablets contain the active ingredient etoricoxib. It acts as a selective cyclooxygenase-2 (COX-2) inhibitor, reducing prostaglandin synthesis involved in pain and inflammation while sparing COX-1 at therapeutic doses. It is indicated for symptomatic treatment of osteoarthritis, rheumatoid arthritis, ankylosing spondylitis and acute gouty arthritis, for short-term management of acute pain including postoperative dental pain, and for primary dysmenorrhea where locally approved. Available by prescription as film-coated tablets in packs of 28.
- Brand: ETORIA
- Active Ingredient: Etoricoxib
- Strength: 90mg
- Dosage Form: Film-coated tablet
- Pack Size: 28 Tablets
- Route: Oral use
- Prescription Status: Prescription
- Therapeutic Class: Analgesic
- Pharmacological Group: COX-2 Inhibitors
- Drug Class: Selective COX-2 Inhibitor (Coxib) NSAID
- Manufacturer: Rovi Pharma Industrial Service
- Country of Origin: Spain
- SFDA Registration No.: 1512211481
- Shelf Life: 36 months
- Storage: do not store above 30°c
- Pain Type: Joint, Muscular
- Nsaid: Yes
- Opioid: No

Frequently bought together

Description

Specification

Indications

Approved Uses

Symptomatic treatment of osteoarthritis, rheumatoid arthritis, ankylosing spondylitis, and acute gouty arthritis; short‑term treatment of acute pain including postoperative dental surgery pain; primary dysmenorrhea (where locally approved).

Off-Label Uses

Chronic low back pain and other musculoskeletal pain syndromes (off‑label depending on jurisdiction); postoperative pain beyond labeled dental surgery indications (off‑label).

Pharmacology

Mechanism of Action

Selective cyclooxygenase‑2 (COX‑2) inhibition, reducing prostaglandin synthesis involved in pain and inflammation, with relatively minimal COX‑1 inhibition at therapeutic doses.

Duration of Effect

Approximately 24 hours.

Half-Life

Approximately 22 hours.

Bioavailability

Oral bioavailability is high, approximately ~100% (near complete).

Protein Binding

Approximately 92%.

Product Information

Available Dosage Forms

Film-coated tablet.

Composition per Dose

Each film-coated tablet: Etoricoxib 90 mg

Generic Availability

Yes

Pain Type

Joint, Muscular

Nsaid

Yes

Opioid

Legal Disclaimer - Al Mujtama Pharmacy

The product information provided is derived from verified pharmaceutical references and is intended for general health education only. It is not a substitute for professional medical advice, diagnosis, or treatment.

Al Mujtama Pharmacy assumes no legal or medical liability for:

Any therapeutic decision made based on the information displayed without consulting a licensed physician or pharmacist
Any discrepancy between the information provided and the product's package insert or SFDA guidelines
Any misuse of medication resulting from personal interpretation of the content displayed

Important notice: Drug formulations and instructions may vary between production batches. Always rely on the leaflet included inside the product packaging you have, and consult your pharmacist or physician before starting, adjusting, or discontinuing any medication.

By using this content, you acknowledge that you have read this disclaimer and agree that Al Mujtama Pharmacy bears no liability arising from reliance on this information as a substitute for direct medical consultation.

Your health is a trust - always consult your doctor first.